SpringWorks Therapeutics is a biopharmaceutical company based in Durham, NC, dedicated to unlocking the full potential of targeted oncology. With a relentless pursuit of new cancer breakthroughs, they bring tenacity to their work every day to provide answers and solutions for patients in need. Their focus areas include rare oncology, BCMA combinations in multiple myeloma, and biomarker-defined metastatic solid tumors, with the aim of developing best-in-class treatments for devastating diseases.
Driven by their core values of caring deeply, ambition without ego, thinking deeply and acting quickly, never settling for good enough, and working together as a team, SpringWorks Therapeutics is committed to making a difference in the lives of people living with severe rare diseases and devastating cancers. Through their precision oncology approach and collaboration with industry and academia, they strive to develop new treatments that can potentially address a significant portion of solid tumor patients and improve their quality of life.
Generated from the website